{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:55:12Z","timestamp":1793213712543,"version":"4.5.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100005831","name":"Foundation for Anesthesia Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005831","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12931-017-0679-6","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T11:39:09Z","timestamp":1512387549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":125,"title":["Autonomic nervous system involvement in pulmonary arterial hypertension"],"prefix":"10.1186","volume":"18","author":[{"given":"Myl\u00e8ne","family":"Vaillancourt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shervin","family":"Sarji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Hoftman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregoire","family":"Ruffenach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoureh","family":"Eghbali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8036-3079","authenticated-orcid":false,"given":"Soban","family":"Umar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"679_CR1","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1161\/CIRCULATIONAHA.114.006980","volume":"131","author":"BA Maron","year":"2015","unstructured":"Maron BA, Leopold JA. Emerging concepts in the molecular basis of pulmonary arterial hypertension. Circulation. 2015;131:2079\u201391.","journal-title":"Circulation"},{"key":"679_CR2","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1001\/jama.1997.03550230093050","volume":"278","author":"TL Guidotti","year":"1997","unstructured":"Guidotti TL. The lung: scientific foundations. JAMA. 1997;278:2117.","journal-title":"JAMA"},{"key":"679_CR3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1378\/chest.77.4.525","volume":"77","author":"CE Juratsch","year":"1980","unstructured":"Juratsch CE, Jengo JA, Castagna J, Laks MM. Experimental pulmonary hypertension produced by surgical and chemical denervation of the pulmonary vasculature. Chest. 1980;77:525\u201330.","journal-title":"Chest"},{"key":"679_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0304-3940(96)12732-4","volume":"211","author":"P Barth\u00e9l\u00e9my","year":"1996","unstructured":"Barth\u00e9l\u00e9my P, Sabeur G, Jammes Y. Assessment of an airway-to-pulmonary circulation reflex in cats. Neurosci Lett. 1996;211:89\u201392.","journal-title":"Neurosci Lett"},{"key":"679_CR5","doi-asserted-by":"crossref","unstructured":"Szidon JP, Flint JF. Significance of sympathetic innervation of pulmonary vessels in response to acute hypoxia. J Appl Physiol. 1977;43:65\u201371.","DOI":"10.1152\/jappl.1977.43.1.65"},{"key":"679_CR6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.RES.70.2.364","volume":"70","author":"TJ McMahon","year":"1992","unstructured":"McMahon TJ, Hood JS, Kadowitz PJ. Pulmonary vasodilator response to vagal stimulation is blocked by N omega-nitro-L-arginine methyl ester in the cat. Circ Res. 1992;70:364\u20139.","journal-title":"Circ Res"},{"key":"679_CR7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1513\/pats.201101-013MW","volume":"8","author":"W Kummer","year":"2011","unstructured":"Kummer W. Pulmonary vascular innervation and its role in responses to hypoxia: size matters! Proc Am Thorac Soc. 2011;8:471\u20136.","journal-title":"Proc Am Thorac Soc"},{"key":"679_CR8","volume-title":"Basics of anesthesia","author":"D Glick","year":"2011","unstructured":"Glick D. Autonomic nervous system. In: Miller RD, Pardo Jr MC, editors. Basics of anesthesia. 6th ed. Philadelphia: Elsevier Saunders; 2011.","edition":"6"},{"key":"679_CR9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00004728-199807000-00012","volume":"22","author":"A Jerzewski","year":"1998","unstructured":"Jerzewski A, Pattynama PM, Steendijk P, Leeuwenburgh BP, de Roos A, Baan J. Differential response of the right and left ventricle to beta-adrenergic stimulation: an echo planar MR study in intact animals. J Comput Assist Tomogr. 1998;22:569\u201376.","journal-title":"J Comput Assist Tomogr"},{"key":"679_CR10","doi-asserted-by":"crossref","first-page":"H2013","DOI":"10.1152\/ajpheart.00167.2006","volume":"291","author":"G-Y Wang","year":"2006","unstructured":"Wang G-Y, McCloskey DT, Turcato S, Swigart PM, Simpson PC, Baker AJ. Contrasting inotropic responses to alpha1-adrenergic receptor stimulation in left versus right ventricular myocardium. Am J Physiol Heart Circ Physiol. 2006;291:H2013\u20137.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"679_CR11","volume-title":"Fundamental Neuroscience","author":"L Squire","year":"2008","unstructured":"Squire L, Berg D, Bloom F, du Lac S, Ghosh A, Spitzer N. Fundamental Neuroscience. 3rd ed. London: Academic Press; 2008.","edition":"3"},{"key":"679_CR12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1164\/rccm.201203-0411OC","volume":"186","author":"FS de Man","year":"2012","unstructured":"de Man FS, Tu L, Handoko ML, Rain S, Ruiter G, Fran\u00e7ois C, et al. Dysregulated Renin\u2013Angiotensin\u2013Aldosterone system contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186:780\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"679_CR13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11906-014-0469-1","volume":"16","author":"AM Hilzendeger","year":"2014","unstructured":"Hilzendeger AM, Shenoy V, Raizada MK, Katovich MJ. Neuroinflammation in pulmonary hypertension: concept, facts, and relevance. Curr Hypertens Rep. 2014;16:469.","journal-title":"Curr Hypertens Rep"},{"key":"679_CR14","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/01.CIR.0000140724.90898.D3","volume":"110","author":"S Velez-Roa","year":"2004","unstructured":"Velez-Roa S, Ciarka A, Najem B, Vachiery J-L, Naeije R, van de Borne P. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation. 2004;110:1308\u201312.","journal-title":"Circulation"},{"key":"679_CR15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1164\/rccm.200912-1856OC","volume":"181","author":"A Ciarka","year":"2010","unstructured":"Ciarka A, Doan V, Velez-Roa S, Naeije R, van de Borne P. Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;181:1269\u201375.","journal-title":"Am J Respir Crit Care Med"},{"key":"679_CR16","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/0735-1097(95)00399-1","volume":"26","author":"M Nootens","year":"1995","unstructured":"Nootens M, Kaufmann E, Rector T, Toher C, Judd D, Francis GS, et al. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol. 1995;26:1581\u20135.","journal-title":"J Am Coll Cardiol"},{"key":"679_CR17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.CIR.102.8.865","volume":"102","author":"N Nagaya","year":"2000","unstructured":"Nagaya N, Nishikimi T, Uematsu M, Satoh T, Kyotani S, Sakamaki F, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation. 2000;102:865\u201370.","journal-title":"Circulation"},{"key":"679_CR18","doi-asserted-by":"crossref","first-page":"R1153","DOI":"10.1152\/ajpregu.00652.2011","volume":"302","author":"S Mak","year":"2012","unstructured":"Mak S, Witte KK, Al-Hesayen A, Granton JJ, Parker JD. Cardiac sympathetic activation in patients with pulmonary arterial hypertension. Am J Physiol Regul Integr Comp Physiol. 2012;302:R1153\u20137.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"679_CR19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.RES.59.3.297","volume":"59","author":"MR Bristow","year":"1986","unstructured":"Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, et al. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res. 1986;59:297\u2013309.","journal-title":"Circ Res"},{"key":"679_CR20","first-page":"2337","volume":"73","author":"M Ishikawa","year":"2009","unstructured":"Ishikawa M, Sato N, Asai K, Takano T, Mizuno K. Effects of a pure alpha\/beta-adrenergic receptor blocker on monocrotaline-induced pulmonary arterial hypertension with right ventricular hypertrophy in rats. Circ J Off J Jpn Circ Soc. 2009;73:2337\u201341.","journal-title":"Circ J Off J Jpn Circ Soc"},{"key":"679_CR21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1164\/rccm.201003-0335OC","volume":"182","author":"HJ Bogaard","year":"2010","unstructured":"Bogaard HJ, Natarajan R, Mizuno S, Abbate A, Chang PJ, Chau VQ, et al. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. Am J Respir Crit Care Med. 2010;182:652\u201360.","journal-title":"Am J Respir Crit Care Med"},{"key":"679_CR22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00109-015-1251-9","volume":"93","author":"K Okumura","year":"2015","unstructured":"Okumura K, Kato H, Honjo O, Breitling S, Kuebler WM, Sun M, et al. Carvedilol improves biventricular fibrosis and function in experimental pulmonary hypertension. J Mol Med. 2015;93:663\u201374.","journal-title":"J Mol Med"},{"key":"679_CR23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physiolgenomics.00166.2012","volume":"45","author":"JI Drake","year":"2013","unstructured":"Drake JI, Gomez-Arroyo J, Dumur CI, Kraskauskas D, Natarajan R, Bogaard HJ, et al. Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonary hypertension. Physiol Genomics. 2013;45:449\u201361.","journal-title":"Physiol Genomics"},{"key":"679_CR24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0002-9149(97)00874-6","volume":"81","author":"RA Quaife","year":"1998","unstructured":"Quaife RA, Christian PE, Gilbert EM, Datz FL, Volkman K, Bristow MR. Effects of Carvedilol on right ventricular function in chronic heart failure. Am J Cardiol. 1998;81:247\u201350.","journal-title":"Am J Cardiol"},{"key":"679_CR25","doi-asserted-by":"crossref","unstructured":"Grinnan D, Bogaard H-J, Grizzard J, Van Tassell B, Abbate A, DeWilde C, et al. Treatm\\ent of group I pulmonary arterial hypertension with Carvedilol is safe. Am J Respir Crit Care Med. 2014;189:1562\u20134.","DOI":"10.1164\/rccm.201311-2025LE"},{"key":"679_CR26","doi-asserted-by":"publisher","unstructured":"Farha S, Saygin D, Park MM, Cheong HI, Asosingh K, Comhair SA, et al. Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trial. JCI Insight. 2017;2(16). doi: 10.1172\/jci.insight.95240","DOI":"10.1172\/jci.insight.95240"},{"key":"679_CR27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/CIRCHEARTFAILURE.111.964494","volume":"5","author":"FS Man de","year":"2012","unstructured":"de Man FS, Handoko ML, van Ballegoij JJM, Schalij I, Bogaards SJP, Postmus PE, et al. Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. Circ Heart Fail. 2012;5:97\u2013105.","journal-title":"Circ Heart Fail"},{"issue":"3","key":"679_CR28","doi-asserted-by":"crossref","first-page":"e000716","DOI":"10.1161\/JAHA.113.000716","volume":"3","author":"S Rain","year":"2014","unstructured":"Rain S, Bos Dda G, Handoko ML, Westerhof N, Stienen G, Ottenheijm C, et al. Protein changes contributing to right ventricular Cardiomyocyte diastolic dysfunction in pulmonary arterial hypertension. J Am Heart Assoc. 2014;3(3):e000716.","journal-title":"J Am Heart Assoc"},{"key":"679_CR29","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1183\/13993003.00090-2016","volume":"48","author":"JSJA Campen van","year":"2016","unstructured":"van Campen JSJA, de Boer K, van de Veerdonk MC, van der Bruggen CEE, Allaart CP, Raijmakers PG, et al. Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study. Eur Respir J. 2016;48:787\u201396.","journal-title":"Eur Respir J"},{"key":"679_CR30","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jacc.2014.11.050","volume":"65","author":"F Perros","year":"2015","unstructured":"Perros F, Ranchoux B, Izikki M, Bentebbal S, Happ\u00e9 C, Antigny F, et al. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension. J Am Coll Cardiol. 2015;65:668\u201380.","journal-title":"J Am Coll Cardiol"},{"key":"679_CR31","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.00215514","volume":"46","author":"D Bandyopadhyay","year":"2015","unstructured":"Bandyopadhyay D, Bajaj NS, Zein J, Minai OA, Dweik RA. Outcomes of \u03b2-blocker use in pulmonary arterial hypertension: a propensity-matched analysis. Eur Respir J. 2015;46:750\u201360.","journal-title":"Eur Respir J"},{"key":"679_CR32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijcard.2015.02.033","volume":"184","author":"C Moretti","year":"2015","unstructured":"Moretti C, Grosso Marra W, D\u2019Ascenzo F, Omed\u00e8 P, Cannillo M, Libertucci D, et al. Beta blocker for patients with pulmonary arterial hypertension: a single center experience. Int J Cardiol. 2015;184:528\u201332.","journal-title":"Int J Cardiol"},{"key":"679_CR33","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.amjcard.2012.01.368","volume":"109","author":"PP-S So","year":"2012","unstructured":"So PP-S, Davies RA, Chandy G, Stewart D, Beanlands RSB, Haddad H, et al. Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension. Am J Cardiol. 2012;109:1504\u20139.","journal-title":"Am J Cardiol"},{"key":"679_CR34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/CIRCHEARTFAILURE.114.001429","volume":"7","author":"T Thenappan","year":"2014","unstructured":"Thenappan T, Roy SS, Duval S, Glassner-Kolmin C, Gomberg-Maitland M. \u03b2-blocker therapy is not associated with adverse outcomes in patients with pulmonary arterial hypertension: a propensity score analysis. Circ Heart Fail. 2014;7:903\u201310.","journal-title":"Circ Heart Fail"},{"key":"679_CR35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/682223","volume":"5","author":"MR Bristow","year":"2015","unstructured":"Bristow MR, Quaife RA. The adrenergic system in pulmonary arterial hypertension: bench to bedside (2013 Grover conference series). Pulm Circ. 2015;5:415\u201323.","journal-title":"Pulm Circ"},{"key":"679_CR36","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/thx.2008.111955","volume":"65","author":"A Peacock","year":"2010","unstructured":"Peacock A, Ross K. Pulmonary hypertension: a contraindication to the use of \u03b2-adrenoceptor blocking agents. Thorax. 2010;65:454\u20135.","journal-title":"Thorax"},{"key":"679_CR37","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM197110142851602","volume":"285","author":"DL Eckberg","year":"1971","unstructured":"Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med. 1971;285:877\u201383.","journal-title":"N Engl J Med"},{"key":"679_CR38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-9149(87)90795-8","volume":"59","author":"RE Kleiger","year":"1987","unstructured":"Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256\u201362.","journal-title":"Am J Cardiol"},{"key":"679_CR39","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.jacc.2007.08.043","volume":"50","author":"GM De Ferrari","year":"2007","unstructured":"De Ferrari GM, Sanzo A, Bertoletti A, Specchia G, Vanoli E, Schwartz PJ. Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol. 2007;50:2285\u201390.","journal-title":"J Am Coll Cardiol"},{"key":"679_CR40","doi-asserted-by":"crossref","unstructured":"Folino AF, Bobbo F, Schiraldi C, Tona F, Romano S, Buja G, et al. Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension. Lung. 2003;181:321\u20138.","DOI":"10.1007\/s00408-003-1034-x"},{"key":"679_CR41","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1183\/09031936.00145708","volume":"34","author":"R Wensel","year":"2009","unstructured":"Wensel R, Jilek C, D\u00f6rr M, Francis DP, Stadler H, Lange T, et al. Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension. Eur Respir J. 2009;34:895\u2013901.","journal-title":"Eur Respir J"},{"key":"679_CR42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijcard.2008.12.087","volume":"142","author":"AE Lammers","year":"2010","unstructured":"Lammers AE, Munnery E, Hislop AA, Haworth SG. Heart rate variability predicts outcome in children with pulmonary arterial hypertension. Int J Cardiol. 2010;142:159\u201365.","journal-title":"Int J Cardiol"},{"key":"679_CR43","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.hrtlng.2014.05.010","volume":"43","author":"H-T Yi","year":"2014","unstructured":"Yi H-T, Hsieh Y-C, Wu T-J, Huang J-L, Lin W-W, Liang K-W, et al. Heart rate variability parameters and ventricular arrhythmia correlate with pulmonary arterial pressure in adult patients with idiopathic pulmonary arterial hypertension. Heart Lung J Acute Crit Care. 2014;43:534\u201340.","journal-title":"Heart Lung J Acute Crit Care"},{"key":"679_CR44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1183\/09031936.00091609","volume":"34","author":"R Naeije","year":"2009","unstructured":"Naeije R, van de Borne P. Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension. Eur Respir J. 2009;34:792\u20134.","journal-title":"Eur Respir J"},{"key":"679_CR45","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1183\/09031936.00165509","volume":"35","author":"B Raffestin","year":"2010","unstructured":"Raffestin B, Leroy M. Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension. Eur Respir J. 2010;35:704\u20135.","journal-title":"Eur Respir J"},{"key":"679_CR46","doi-asserted-by":"crossref","first-page":"H2230","DOI":"10.1152\/ajpheart.01226.2010","volume":"300","author":"D Benoist","year":"2011","unstructured":"Benoist D, Stones R, Drinkhill M, Bernus O, White E. Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. Am J Physiol Heart Circ Physiol. 2011;300:H2230\u20137.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"679_CR47","doi-asserted-by":"crossref","first-page":"H2381","DOI":"10.1152\/ajpheart.01084.2011","volume":"302","author":"D Benoist","year":"2012","unstructured":"Benoist D, Stones R, Drinkhill MJ, Benson AP, Yang Z, Cassan C, et al. Cardiac arrhythmia mechanisms in rats with heart failure induced by pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2012;302:H2381\u201395.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"679_CR48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCEP.111.967265","volume":"5","author":"S Umar","year":"2012","unstructured":"Umar S, Lee J-H, de Lange E, Iorga A, Partow-Navid R, Bapat A, et al. Spontaneous ventricular fibrillation in right ventricular failure secondary to chronic pulmonary hypertension. Circ Arrhythm Electrophysiol. 2012;5:181\u201390.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"679_CR49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ahj.2006.09.008","volume":"153","author":"J Tongers","year":"2007","unstructured":"Tongers J, Schwerdtfeger B, Klein G, Kempf T, Schaefer A, Knapp J-M, et al. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J. 2007;153:127\u201332.","journal-title":"Am Heart J"},{"key":"679_CR50","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.ijcard.2012.06.024","volume":"167","author":"KM Olsson","year":"2013","unstructured":"Olsson KM, Nickel NP, Tongers J, Hoeper MM. Atrial flutter and fibrillation in patients with pulmonary hypertension. Int J Cardiol. 2013;167:2300\u20135.","journal-title":"Int J Cardiol"},{"key":"679_CR51","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.amjcard.2014.07.079","volume":"114","author":"L Wen","year":"2014","unstructured":"Wen L, Sun M-L, An P, Jiang X, Sun K, Zheng L, et al. Frequency of supraventricular arrhythmias in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol. 2014;114:1420\u20135.","journal-title":"Am J Cardiol"},{"key":"679_CR52","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.amjcard.2015.09.039","volume":"116","author":"M Cannillo","year":"2015","unstructured":"Cannillo M, Grosso Marra W, Gili S, D\u2019Ascenzo F, Morello M, Mercante L, et al. Supraventricular arrhythmias in patients with pulmonary arterial hypertension. Am J Cardiol. 2015;116:1883\u20139.","journal-title":"Am J Cardiol"},{"key":"679_CR53","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.hlc.2015.10.008","volume":"25","author":"K Ma\u0142aczy\u0144ska-Rajpold","year":"2016","unstructured":"Ma\u0142aczy\u0144ska-Rajpold K, Komosa A, B\u0142aszyk K, Araszkiewicz A, Janus M, Olasi\u0144ska-Wi\u015bniewska A, et al. The Management of Supraventricular Tachyarrhythmias in patients with pulmonary arterial hypertension. Heart Lung Circ. 2016;25:442\u201350.","journal-title":"Heart Lung Circ"},{"key":"679_CR54","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1086\/675984","volume":"4","author":"BA Maron","year":"2014","unstructured":"Maron BA, Leopold JA. The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover conference series). Pulm Circ. 2014;4:200\u201310.","journal-title":"Pulm Circ"},{"key":"679_CR55","first-page":"33","volume":"70","author":"TV Martyniuk","year":"1998","unstructured":"Martyniuk TV, Chazova IE, Masenko VP, Volkov VN, Belenkov IN. Activity of renin-angiotensin-aldosterone system (RAAS) and vasopressin level in patients with primary pulmonary hypertension. Ter Arkh. 1998;70:33\u20136.","journal-title":"Ter Arkh"},{"key":"679_CR56","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0022-3565(25)10914-2","volume":"262","author":"LA Cassis","year":"1992","unstructured":"Cassis LA, Rippetoe PE, Soltis EE, Painter DJ, Fitz R, Gillespie MN. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist. J Pharmacol Exp Ther. 1992;262:1168\u201372.","journal-title":"J Pharmacol Exp Ther"},{"key":"679_CR57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10641969609082610","volume":"18","author":"R Kreutz","year":"1996","unstructured":"Kreutz R, Fernandez-Alfonso MS, Ganten D, Paul M. Effect of losartan on right ventricular hypertrophy and cardiac angiotensin I-converting enzyme activity in pulmonary hypertensive rats. Clin Exp Hypertens. 1996;18:101\u201311.","journal-title":"Clin Exp Hypertens"},{"key":"679_CR58","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijcard.2013.08.102","volume":"169","author":"MA Borgdorff","year":"2013","unstructured":"Borgdorff MA, Bartelds B, Dickinson MG, Steendijk P, Berger RMF. A cornerstone of heart failure treatment is not effective in experimental right ventricular failure. Int J Cardiol. 2013;169:183\u20139.","journal-title":"Int J Cardiol"},{"key":"679_CR59","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.cardfail.2014.08.003","volume":"20","author":"S Andersen","year":"2014","unstructured":"Andersen S, Schultz JG, Andersen A, Ringgaard S, Nielsen JM, Holmboe S, et al. Effects of Bisoprolol and Losartan treatment in the hypertrophic and failing right heart. J Card Fail. 2014;20:864\u201373.","journal-title":"J Card Fail"},{"key":"679_CR60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5152\/akd.2010.010","volume":"10","author":"SS Bozba\u015f","year":"2010","unstructured":"Bozba\u015f SS, Bozba\u015f H, Atar A, Ulubay G, Oner Ey\u00fcbo\u011flu F. Comparative effects of losartan and nifedipine therapy on exercise capacity, Doppler echocardiographic parameters and endothelin levels in patients with secondary pulmonary hypertension. Anadolu Kardiyol Derg. 2010;10:43\u20139.","journal-title":"Anadolu Kardiyol Derg"},{"key":"679_CR61","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1164\/rccm.200811-1678OC","volume":"179","author":"AJ Ferreira","year":"2009","unstructured":"Ferreira AJ, Shenoy V, Yamazato Y, Sriramula S, Francis J, Yuan L, et al. Evidence for Angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. Am J Respir Crit Care Med. 2009;179:1048\u201354.","journal-title":"Am J Respir Crit Care Med"},{"key":"679_CR62","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/bph.13044","volume":"172","author":"E Bruce","year":"2015","unstructured":"Bruce E, Shenoy V, Rathinasabapathy A, Espejo A, Horowitz A, Oswalt A, et al. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis. Br J Pharmacol. 2015;172:2219\u201331.","journal-title":"Br J Pharmacol"},{"key":"679_CR63","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/HYPERTENSIONAHA.114.03871","volume":"64","author":"V Shenoy","year":"2014","unstructured":"Shenoy V, Kwon K-C, Rathinasabapathy A, Lin S, Jin G, Song C, et al. Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension. Hypertension. 2014;64:1248\u201359.","journal-title":"Hypertension"},{"key":"679_CR64","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00408-013-9470-8","volume":"191","author":"G Li","year":"2013","unstructured":"Li G, Liu Y, Zhu Y, Liu A, Xu Y, Li X, et al. ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats. Lung. 2013;191:327\u201336.","journal-title":"Lung"},{"key":"679_CR65","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2013.04.017","volume":"713","author":"K Rigatto","year":"2013","unstructured":"Rigatto K, Casali KR, Shenoy V, Katovich MJ, Raizada MK. Diminazene aceturate improves autonomic modulation in pulmonary hypertension. Eur J Pharmacol. 2013;713:89\u201393.","journal-title":"Eur J Pharmacol"},{"key":"679_CR66","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/CIRCULATIONAHA.112.094722","volume":"126","author":"BA Maron","year":"2012","unstructured":"Maron BA, Zhang Y-Y, White K, Chan SY, Handy DE, Mahoney CE, et al. Aldosterone inactivates the Endothelin-B receptor via a Cysteinyl Thiol Redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial HypertensionClinical perspective. Circulation. 2012;126:963\u201374.","journal-title":"Circulation"},{"key":"679_CR67","doi-asserted-by":"crossref","first-page":"L678","DOI":"10.1152\/ajplung.00300.2012","volume":"304","author":"IR Preston","year":"2013","unstructured":"Preston IR, Sagliani KD, Warburton RR, Hill NS, Fanburg BL, Jaffe IZ. Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2013;304:L678\u201388.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"679_CR68","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/eurjhf\/hfs173","volume":"15","author":"BA Maron","year":"2013","unstructured":"Maron BA, Opotowsky AR, Landzberg MJ, Loscalzo J, Waxman AB, Leopold JA. Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study. Eur J Heart Fail. 2013;15:277\u201383.","journal-title":"Eur J Heart Fail"},{"key":"679_CR69","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.amjcard.2013.04.051","volume":"112","author":"BA Maron","year":"2013","unstructured":"Maron BA, Waxman AB, Opotowsky AR, Gillies H, Blair C, Aghamohammadzadeh R, et al. Effectiveness of Spironolactone plus Ambrisentan for treatment of pulmonary arterial hypertension (from the [ARIES] study 1 and 2 trials). Am J Cardiol. 2013;112:720\u20135.","journal-title":"Am J Cardiol"},{"key":"679_CR70","doi-asserted-by":"crossref","unstructured":"Safdar Z, Thakur A, Singh S, Ji Y, Guffey D, Minard CG, et al. Circulating Aldosterone Levels and Disease Severity in Pulmonary Arterial Hypertension. J Pulm Respir Med. 2015;5(5). Epub ahead of print","DOI":"10.4172\/2161-105X.1000295"},{"key":"679_CR71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/HYPERTENSIONAHA.113.01979","volume":"63","author":"S Na","year":"2014","unstructured":"Na S, Kim OS, Ryoo S, Kweon TD, Choi YS, Shim HS, et al. Cervical ganglion block attenuates the progression of pulmonary hypertension via nitric oxide and Arginase PathwaysNovelty and significance. Hypertension. 2014;63:309\u201315.","journal-title":"Hypertension"},{"key":"679_CR72","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4244\/EIJV9I2A43","volume":"9","author":"S-L Chen","year":"2013","unstructured":"Chen S-L, Zhang Y-J, Zhou L, Xie D-J, Zhang F-F, Jia H-B, et al. Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo. EuroIntervention. 2013;9:269\u201376.","journal-title":"EuroIntervention"},{"key":"679_CR73","doi-asserted-by":"crossref","first-page":"e002569","DOI":"10.1161\/CIRCINTERVENTIONS.115.002569","volume":"8","author":"AMK Rothman","year":"2015","unstructured":"Rothman AMK, Arnold ND, Chang W, Watson O, Swift AJ, Condliffe R, et al. Pulmonary artery Denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension. Circ Cardiovasc Interv. 2015;8:e002569.","journal-title":"Circ Cardiovasc Interv."},{"key":"679_CR74","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2013.05.075","volume":"62","author":"S-L Chen","year":"2013","unstructured":"Chen S-L, Zhang F-F, Xu J, Xie D-J, Zhou L, Nguyen T, et al. Pulmonary artery Denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery Denervation for treatment of pulmonary artery hypertension). J Am Coll Cardiol. 2013;62:1092\u2013100.","journal-title":"J Am Coll Cardiol"},{"key":"679_CR75","doi-asserted-by":"crossref","first-page":"e002837","DOI":"10.1161\/CIRCINTERVENTIONS.115.002837","volume":"8","author":"S-L Chen","year":"2015","unstructured":"Chen S-L, Zhang H, Xie D-J, Zhang J, Zhou L, Rothman AMK, et al. Hemodynamic, functional, and clinical responses to pulmonary artery Denervation in patients with pulmonary arterial hypertension of different causes. Circ Cardiovasc Interv. 2015;8:e002837.","journal-title":"Circ Cardiovasc Interv"},{"key":"679_CR76","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.recesp.2014.11.025","volume":"68","author":"Z Qingyan","year":"2015","unstructured":"Qingyan Z, Xuejun J, Yanhong T, Zixuan D, Xiaozhan W, Xule W, et al. Beneficial effects of renal Denervation on pulmonary vascular remodeling in experimental pulmonary artery hypertension. Rev Esp Cardiol. 2015;68:562\u201370.","journal-title":"Rev Esp Cardiol"},{"key":"679_CR77","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","volume":"370","author":"DL Bhatt","year":"2014","unstructured":"Bhatt DL, Kandzari DE, O\u2019Neill WW, D\u2019Agostino R, Flack JM, Katzen BT, et al. A controlled trial of renal Denervation for resistant hypertension. N Engl J Med. 2014;370:1393\u2013401.","journal-title":"N Engl J Med"},{"issue":"29","key":"679_CR78","doi-asserted-by":"crossref","first-page":"46846","DOI":"10.18632\/oncotarget.15154","volume":"8","author":"Q Liu","year":"2017","unstructured":"Liu Q, Song J, Lu D, Geng J, Jiang Z, Wang K, et al. Effects of renal denervation on monocrotaline induced pulmonary remodeling. Oncotarget. 2017 Jul 18;8(29):46846\u201355.","journal-title":"Oncotarget"},{"key":"679_CR79","unstructured":"Chapter 14. Adrenergic Agonists & Antagonists. In: Butterworth JF, Mackey DC, Wasnick JD. Morgan Mikhails Clinical Anesthesiology. 5th ed. New York: The McGraw-Hill Companies; 2013. https:\/\/accessmedicine.mhmedical.com\/content.aspx?aid=57231933"},{"key":"679_CR80","volume-title":"Pathophysiology of disease: an introduction to clinical medicine","author":"T Else","year":"2013","unstructured":"Else T, Hammer GD. Disorders of the adrenal medulla. In: Hammer GD, McPhee SJ, editors. Pathophysiology of disease: an introduction to clinical medicine. 7th ed. New York: McGraw-Hill; 2013. http:\/\/accessmedicine.mhmedical.com\/content.aspx?bookid=961&sectionid=53555693 .","edition":"7"},{"key":"679_CR81","unstructured":"Douglas IS. Acute right heart syndromes. In: Hall JB, Schmidt GA, Kress JP, editors. Principles of critical care. 4th ed. New York: McGraw-Hill Education; 2015. http:\/\/accessmedicine.mhmedical.com\/content.aspx?sectionid=80031364&bookid=1340&Resultclick=2 ."},{"key":"679_CR82","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/cvr\/cvm008","volume":"77","author":"V Leblais","year":"2008","unstructured":"Leblais V, Delannoy E, Fresquet F, B\u00e9gueret H, Bellance N, Banquet S, et al. \u03b2-adrenergic relaxation in pulmonary arteries: preservation of the endothelial nitric oxide-dependent \u03b22 component in pulmonary hypertension. Cardiovasc Res. 2008;77:202\u201310.","journal-title":"Cardiovasc Res"},{"key":"679_CR83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2012.11.001","volume":"698","author":"J P\u00e9rez-Schindler","year":"2013","unstructured":"P\u00e9rez-Schindler J, Philp A, Hernandez-Cascales J. Pathophysiological relevance of the cardiac \u03b22-adrenergic receptor and its potential as a therapeutic target to improve cardiac function. Eur J Pharmacol. 2013;698:39\u201347.","journal-title":"Eur J Pharmacol"},{"key":"679_CR84","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1513\/pats.200504-043SR","volume":"2","author":"KE Belmonte","year":"2005","unstructured":"Belmonte KE. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:297\u2013304.","journal-title":"Proc Am Thorac Soc"},{"key":"679_CR85","unstructured":"Chapter 60. The Autonomic Nervous System and the Adrenal Medulla. In: Guyton, Arthur C. and John E. Hall. Textbook of medical physiology. 11th ed. Philadelphia: Elsevier Inc.2006. https:\/\/www.elsevier.com\/books\/textbook-of-medical-physiology\/hall\/978-0-7216-0240-0"},{"key":"679_CR86","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1440-1681.2010.05448.x","volume":"37","author":"D-L Li","year":"2010","unstructured":"Li D-L, Liu B-H, Sun L, Zhao M, He X, Yu X-J, et al. Alterations of muscarinic acetylcholine receptors-2, 4 and \u03b17-nicotinic acetylcholine receptor expression after ischaemia\u200a\/\u200areperfusion in the rat isolated heart. Clin Exp Pharmacol Physiol. 2010;37:1114\u20139.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"679_CR87","doi-asserted-by":"crossref","first-page":"667","DOI":"10.5306\/wjco.v5.i4.667","volume":"5","author":"X-M Niu","year":"2014","unstructured":"Niu X-M, Lu S. Acetylcholine receptor pathway in lung cancer: new twists to an old story. World J Clin Oncol. 2014;5:667\u201376.","journal-title":"World J Clin Oncol"},{"key":"679_CR88","doi-asserted-by":"crossref","unstructured":"Zhu Y-C, Zhu Y-Z, Lu N, Wang M-J, Wang Y-X, Yao T. Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling. Clin Exp Pharmacol Physiol. 2003;30:911\u20138.","DOI":"10.1111\/j.1440-1681.2003.03942.x"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-017-0679-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:47:06Z","timestamp":1751071626000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-017-0679-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["679"],"URL":"https:\/\/doi.org\/10.1186\/s12931-017-0679-6","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"201"}}